Ferric Contrast
Amherst
About Ferric Contrast
Ferric Contrast is a diagnostic tool developer whose goal is to create the safest MRI contrast agents. The company's technology is iron-based contrast agents that can be used to produce technological magnetic resonance images of the brain, vasculature, liver, and kidneys, as well as to detect tumors caused by cancer, providing customers with a multipurpose agent that can be used to obtain high-quality magnetic resonance images of the brain, vasculature, liver, and kidneys, as well as to detect cancerous tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $974.9K
- Funding stage: Seed
- Last round: Seed (Oct 2022)
- Website: ferric-contrast.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical Device
Canonical: https://fsome.com/organization/ferric-contrast-200407 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.